Publication | Closed Access
Imatinib Mesylate Resistance in a Chronic Myeloid Leukemia Patient with a Novel e8a2 BCR-ABL Transcript Variant
10
Citations
6
References
2008
Year
ABL point mutation is also a mechanism of imatinib resistance for CML patients with the BCR-ABL transcript variant.
| Year | Citations | |
|---|---|---|
Page 1
Page 1